Skip to main content
Signal8

Nabulsi Azmi

SEC insider (Form 3/4/5 filer). CIK 0001791412. Chief Operating Officer at Phathom Pharmaceuticals, Inc. (PHAT). 3 reported Form 4/5 transactions since Sep 2024; latest on Feb 27, 2025. Located in FLORHAM PAK, NJ.

Companies Nabulsi Azmi has filed insider reports for

  • Phathom Pharmaceuticals, Inc. (PHAT): Officer, Chief Operating Officer
Nabulsi Azmi profile photo

Nabulsi Azmi

CIK: 0001791412

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)2 (66.7%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Phathom Pharmaceuticals, Inc. logo
PHAT

Phathom Pharmaceuticals, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • Phathom Pharmaceuticals, Inc. logo
    PHAT

    Phathom Pharmaceuticals, Inc.

    Feb 27, 2025
    Award
    Direct
    79.2K shares-
  • Phathom Pharmaceuticals, Inc. logo
    PHAT

    Phathom Pharmaceuticals, Inc.

    Jan 21, 2025
    Sale
    Direct
    7.9K shares at avg. $6.59$52K
  • Phathom Pharmaceuticals, Inc. logo
    PHAT

    Phathom Pharmaceuticals, Inc.

    Dec 19, 2024
    Sale
    Direct
    1.1K shares at avg. $8.00$9K

1-3 of 3